HonKuwa partners with Prof. Yoshiki Sawa for joint and muscle injury treatments development.

HonKuwa Pharmaceutical Co. Ltd. has partnered with Professor Yoshiki Sawa, a leader in regenerative medicine, appointing him as honorary chief research scientist. This collaboration aims to merge Sawa's expertise in cell biology with HonKuwa's product development to create innovative treatments for joint and muscle injuries. The partnership represents a significant advancement in HonKuwa's global drug research and development efforts.

October 15, 2024
3 Articles